The UC San Diego AntiViral Research Center sponsors weekly presentations on HIV, HBV, HCV, TB and other infectious diseases to provide clinicians, physicians and researchers with the most current research, clinical practices and trends. The slides from an AIDS Clinical Rounds presentation on individualized texting for adherence building (iTAB) are intended for educational purposes and may not be used without permission. The presentation provides an update on iTAB studies with HIV+ individuals with bipolar disorder or active meth use, and HIV- individuals taking PrEP, discussing lessons learned for implementation.

1. AIDS CLINICAL ROUNDS
The UC San Diego AntiViral Research Center sponsors weekly
presentations by infectious disease clinicians, physicians and
researchers. The goal of these presentations is to provide the most
current research, clinical practices and trends in HIV, HBV, HCV, TB
and other infectious diseases of global significance.
The slides from the AIDS Clinical Rounds presentation that you are
about to view are intended for the educational purposes of our
audience. They may not be used for other purposes without the
presenter’s express permission.

2. Update on Individualized Texting for
Adherence Building (iTAB): Lessons for
Implementation
David J. Moore, Ph.D.
University of California, San Diego
Department of Psychiatry
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

3. Brief Outline
 Texting and adherence in HIV
 iTAB System
 Results from completed/ongoing studies
» iTAB-B: HIV+ with bipolar disorder
» iTAB-M: HIV+ with active meth use
» CCTG 595: HIV- taking PrEP
 Conclusions
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

4. Texting Improves ART Adherence
 SMS (texting) interventions for improving ART adherence
show promise
 In a 2012 Cochrane report, two RCTs shown to be
efficacious for ART improvement:
» 1X week text over a 12-month interval decreased non-adherence
and virologic failure (Lester et al., 2010)
» 1X week versus 1X day text messages; at 48-weeks, weekly
messages were more likely to reduce non-adherence and
treatment interruptions (Pop-Eleches et al., 2011)
 Optimal texting systems for adherence improvement in
difficult-to-treat populations in US still evolving
Horvath et al., Cochran Report, 2012; Lester et al., 2010; Pop-Eleches et al. 2011
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

5. Personalized iTAB intervention
 iTAB -- Pts create personalized med reminder texts:
• Description of medications
• Personalized reminder stems (e.g., “remember
to take your meds, they make you healthy”)
• Preferred name
• Ideal time for reminders each day by med
 Both iTAB and CTRL received:
• Adherence psychoeducation (~30 min)
• A daily text message asking about mood
• Process of medication reminder creation
• Sentinel med for MEMS: ARV: Mostly combo
medication; PSY: Primary mood stabilizer
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

6. Example of Customizable iTAB System
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

7. Example of Customizable iTAB System
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

8. iTAB Decision Tree
Other iTAB components:
• 3 consecutive days of non-
responses get a
“noncompliance” text
• 5 consecutive days of non-
responses, call from RA
• Adherence Targets:“Ur
current adherence: xx%.
Adhr when u take ur next
dose: xx% (x/x doses)”
• Personalized Reinforcer
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

9. iTAB Studies
iTAB-B iTAB-M CCTG 595
Group HIV+ Bipolar HIV+ Meth HIV-
Design RCT (n=50) RCT (n=75) RCT (n=400)
Status Enrolled Enrolling (n=23) Start 12/1
Duration 4 weeks 6 weeks 48 weeks
Referrals N/A Please!619-543- 619-543-5011
5000
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

10. iTAB in HIV+ with Bipolar Disorder
(iTAB-B)
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

11. iTAB-B Study Flow
Enrollment
Assessed for eligibility (n=62)
Excluded (n=4)
• Not meeting inclusion criteria (n=2)
• Declined to participate (n=1)
Randomized (n=58) • Withdrawn (n=1)
Allocation
Allocated to iTab intervention Allocated to CTRL intervention
(n=30) (n=28)
Follow-up
Lost to follow up Lost to follow up
(n=2) (n=2)
Analysis
Analyzed (n=25) Analyzed (n=25)
• Lost MEMS (n=3) • Lost MEMS (n=1))
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

12. Example iTAB-B Intervention Stems
Stems of personal reminder messages reflect different themes:
» Celebrate Health » Empowering
• Stay healthy! It’s time 2 • It’s med time, only u can
take ur meds, pls take ur… control this. Rmber 2
» Time and Focus take ur…
• It’s pill time! Take ur… » Importance of Adherence
» Control Disease • Adherence is impt. Pls
• Taking ur meds helps take ur…
control ur disease. Rmber
2 take ur…
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

13. Demographics
CTRL (n=25) ITAB (n=25) P-value
Age 45.9 (10.2) 48.4 (9.2) 0.36
Education 13.0 (3.1) 13.3 (2.2) 0.67
Ethnicity (% White) 44.0 64.0 0.26
Sex (% Male) 84.0 92.0 0.67
Global Deficit Score 0.7 (0.7) 0.6 (0.6) 0.68
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

14. Psychiatric Characteristics
CTRL (n=25) ITAB (n=25) P-value
Lifetime Substance
87.5 68.0 0.10
Diagnosis,%
Current Substance
4.2 4.0 0.98
Diagnosis, %
Euthymic during the
64.0 64.0 0.62
prior month, %
Beck Depression
18.0 (10.6) 17.0 (12.6) 0.77
Inventory–II
Young Mania Rating
5.2 (4.5) 6.4 (7.6) 0.49
Scale
GAF 67.3 (10.9) 68.0 (10.0) 0.82
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

15. Medical Characteristics
CTRL (n=25) ITAB (n=25) P-value
Current CD4 Count 655.8 (324.2) 603.4 (392.8) 0.67
Nadir CD4 Count 225.7 (153.1) 281.2 (258.2) 0.44
HIV RNA Detectable, % 8.0 24.0 0.12
AIDS Status, % 60.9 70.0 0.75
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

16. Medication Characteristics
CTRL (n=25) ITAB (n=25) P-value
Self report % ARV doses
87.9 (16.8) 96.0 (7.2) 0.10
taken (past month)
Self report % PSY doses
89.0 (19.2) 94.1 (9.9) 0.41
taken (past month)
Total No. of ARVs 6.9 (4.5) 7.1 (4.5) 0.75
Total No. of rx doses, ARV 42.7 (13.8) 41.5 (14.2) 0.61
Total No. of rx doses, PSY 47.7 (24.1) 44.7 (19.0) 0.57
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

17. Overall MEMS Adherence by Group
100
90
MEMS % of Prescribed Doeses
80
70
60
Taken
50 CTRL
40 iTAB
30
20
N=25 N=25 N=2 N=25
10 5
0
ARV PSY
p = 0.28 p = 0.94
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

18. Overall MEMS % On Schedule by Group
90
80
70
60
50
CTRL
40
iTAB
30
20
10 N=25 N=25 N=25 N=25
0
ARV PSY
p = 0.25 p = 0.89
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

19. Time from Target Dose by Group
N=25 N=25 N=25 N=25
p = 0.03 p = 0.34
Cohen’s d = -0.33 Cohen’s d = 0.04
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

20. Adherence & Mania Ratings
YMRS total YMRS total
F (1, 49) = 6.774 F (1, 46) = 2.705
p = 0.012 p = 0.107
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

21. Frequency of Stems Selected
Frequency Selected (N=25)
80%
70%
60%
50%
40%
30%
20%
10%
0%
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
# Stem # Stem
1 Ur health is impt, rmber 2 take ur meds. Take ur [med] now. 10 Adherence is impt. Pls take ur [med] now.
2 Stay healthy! It's time 2 take ur meds, pls take ur [med] now. 11 2 help keep u feeling good, rmber 2 take ur [med] now.
3 No matter what else is going on, it's impt 2 take ur [med] now. 12 Ur meds are important. It's time for ur next dose of ur [med] now.
4 It's med time! Pls take ur [med] now. 13 Ready, set, get healthy! It's meds time. Time for ur [med] now.
5 It's med time, only u can control this. Rmber 2 take ur [med] now. 14 Protect ur health. It's that time again 2 take ur [med] now.
6 Taking ur meds helps control ur disease. Rmber 2 take ur [med] now. 15 It's pill time! Take ur [med] now.
7 Yay, health! Don't frgt 2 take ur [med] now. 16 2 control ur health u need 2 take ur [med] now.
8 Taking ur meds helps 2 keep ur body healthy! Take ur [med] now. 17 Other/Custom
9 U've been doing gr8 w/ ur adherence. It's time 2 take ur [med] now.
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

22. Adherence Rates by Stem
Adherence Rate ARV Adherence Rate PSY
100%
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
# Stem # Stem
1 Ur health is impt, rmber 2 take ur meds. Take ur [med] now. 10 Adherence is impt. Pls take ur [med] now.
2 Stay healthy! It's time 2 take ur meds, pls take ur [med] now. 11 2 help keep u feeling good, rmber 2 take ur [med] now.
3 No matter what else is going on, it's impt 2 take ur [med] now. 12 Ur meds are important. It's time for ur next dose of ur [med] now.
4 It's med time! Pls take ur [med] now. 13 Ready, set, get healthy! It's meds time. Time for ur [med] now.
5 It's med time, only u can control this. Rmber 2 take ur [med] now. 14 Protect ur health. It's that time again 2 take ur [med] now.
6 Taking ur meds helps control ur disease. Rmber 2 take ur [med] now. 15 It's pill time! Take ur [med] now.
7 Yay, health! Don't frgt 2 take ur [med] now. 16 2 control ur health u need 2 take ur [med] now.
8 Taking ur meds helps 2 keep ur body healthy! Take ur [med] now. 17 Other/Custom
9 U've been doing gr8 w/ ur adherence. It's time 2 take ur [med] now.
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

23. iTAB in HIV+ METH Users: iTAB-M
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

24. METH is Risk Factor for HIV
 In 2008, 850,000 Americans
≥12 y.o. abused METH in
previous year (National Survey
on Drug Use and Health, 2008)
 CDC estimates 12% of incident
US HIV cases attributable to
IVDU (HIV/AIDS Surveillance
Report, 2007)
 Strong association between
METH use among MSMs and
continued high incidence of
HIV/AIDS in the US (CDC
HIV/AIDS Fact Sheet, 2007)
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

25. iTAB-M Focus Groups
AIM:
 To identify barriers and strategies for ART adherence specific
to HIV+/MA+ persons and to integrate feedback on the content
of the text-message reminders for iTAB-M
METHOD:
 Two focus groups, each with ten HIV+/MA+ individuals, were
conducted
 Participants were middle aged (43.6 years, SD=7.7),
predominantly male (90%), Caucasian (60%), and high school
educated (12.3 years; SD=2.8).
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

26. iTAB-M Focus Group Data Analysis
 Audio recordings transcribed
 Independently coded by two investigators using QSR NVivo
software
 Codes identified emergent themes related to barriers and
strategies of adherence and feedback on the content of
proposed text messages
 Disagreements in coding resolved through consensus
 Kappa calculated for final assigned codes
 High Interrater reliability: kappa = 98.7
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

27. Adherence Barriers in Meth HIV+
Nodes clustered by Word similarity
Mental Health
Lack of Social Support
Pill Burden
Accessibility
Apathy
Cognitive Problems
Medicine Side Effects
Stigma
Lack of Education
Meth-related
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

28. Example: Adherence Barriers
“
My biggest problem was losing track of time,
you know, and so I would have them but I may
take it, you know, 12 hours and then 36 hours
and that kind of deal, but I always adhered. It
was just very sloppy, you know, while I was
using that weekend. So, that was my
”
biggest issue.
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

29. Strategies for Adherence
Nodes clustered by Word similarity
Planning
Health Promotion
Self Efficacy
Spirituality
Pharmacy Assistance
Increase Accessibility
Utilize Reminders
Efficient Medication Regimen
Education
Engagement of Health Care System
Social Support
Token Economy
Self-Esteem
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

30. Strategies for Adherence
“
I was thinking about taking meds and
things like that, if we have something
called the buddy system. Or just maybe
have one of the nurses giving you a call
everyday saying are you taking your
”
meds?
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

31. Meth and Adherence
% of Days Reporting Meth Use Adherence by Meth Status
50% 100%
45% 90%
40% 80%
35% 70%
30% 60%
25% 50%
20% 40%
15% 30%
10% 20%
5% 10%
0% 0%
Control ITAB Meth+ days Meth- days
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

32. Example iTAB-M Intervention Stems
Stems of personal reminder messages reflect different themes:
» Celebrate Health » Self-Esteem
• Stay healthy! It’s time 2 take ur • U are special. Pls take ur…
meds, pls take ur… » Meth Focus
» Time and Focus • Take ur meds so u can keep
• It only takes a second! Take ur… having fun. Time 4 ur…
» Social Support » Dangers of Non-adherence
• People care about u. Pls take • Not taking ur meds could
ur… make u resistant. Take ur…
» Control Disease » Spiritual
• It’s impt to take care of urself. • God grant me the serenity to
Pls take ur… do this. It’s time 4 ur…
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

33. iTAB-M Intervention Stems
# Reminder Stem
1 Stay healthy! It’s time to take your meds, please take your medications.
2 To help keep you feeling good, remember to take your medications.
3 Ready, set, get healthy! It’s med time. Time for your medications.
4 Live longer! Take your medications.
5 Yay, health! Don’t forget to take your medications.
6 It only takes a second! Take your medications.
7 It's med time! Please take your medications.
8 It’s pill time! Take your medications.
9 No matter what else is going on, it’s important to take your medications.
10 Stop everything and take your meds! Take your medications.
11 People care about you. Please take your medications.
12 Think about the people who love you. Take your medications.
13 We care about u and your health. Please take your medications.
14 [name] needs you. Take your medications.
15 You are not alone. It’s time to take your medications.
16 It’s important to take care of yourself. Please take your medications.
17 Your health is important, remember to take your meds. Take your medications.
18 To control your health you need to take your medications.
19 Adherence is important. Please take your medications.
20 Protect your health. It’s that time again to take your medications.
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

34. iTAB-M Intervention Stems
# Reminder Stem
21 You are special. Please take your medications.
22 Stay strong. It’s time for your medications.
23 You’ve been doing great with your adherence. It’s time to take your medications.
24 You can do it! Take your medications.
25 It’s a great accomplishment to be adherent! Take your medications.
26 Take your meds so you can keep having fun. Time for your medications.
27 Ignore Tina and take your medications.
28 It’s not party time; it’s med time! Please take your medications.
29 You can have fun and take your meds. Time for your medications.
30 Stop screwing around and take your medications.
31 Not taking your meds has severe consequences. Take your medications.
32 Not taking your meds could make u resistant. Take your medications.
33 You need your meds to live longer. Time for your medications.
34 You will only get sicker if you don’t take your meds. Time for your medications.
35 Not taking your meds puts others at risk. Please take your medications.
36 God loves you. It’s time for your medications.
37 WWJD? Take his meds! Time for your medications.
38 Trust in the Lord. Take your medications.
39 The Lord believes in you; believe in yourself. Take your medications.
40 God grant me the serenity to do this. It’s time for your medications.
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

35. iTAB-M Frequency of Stem Selection
100% Frequency Selected (N=10)
90% 6. It only takes a second! Take your medications.
80% 8. It’s pill time! Take your medications.
9. No matter what else is going on, it’s important
70% to take your medications.
60%
50%
40%
30%
20%
10%
0%
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

36. Self-reported Adherence by Stem
Adherence Rate by Stem (N=10)
100%
90%
80%
70% Overall Mean: 64.5%
60%
50%
40%
30%
20%
10%
0%
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

37. Frequency Chosen by Adherence
Adherence Rate
100%
90% Frequency Selected (N=10)
80%
70%
60%
50%
40%
30%
20%
10%
0%
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

38. iTAB in HIV- for PrEP: CCTG 595
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

39. Study Design
 Controlled, un-blinded, two-armed, randomized (1:1)
clinical trial in the setting of PrEP implementation at three
HIV testing/ HIV provider sites in Southern California
 Randomized either to
PrEP + SoC or
PrEP + SoC + iTAB
 Duration: endpoint analysis at 48 weeks
 Sample size: 400 subjects, 200 per arm
 Stratification by clinic site
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

40. CCTG 595 Schema
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

41. CCTG 595 Hypotheses
 Objective: To compare adherence to fixed dose TDF/FTC,
between subjects randomized to receive SoC plus text
message reminders versus SoC, when used for pre-
exposure prophylaxis among MSM at high risk for HIV
acquisition
 Hypothesis: MSM and transgender M to F having sex with
men with high risk of HIV acquisition randomized to the
iTAB intervention will have higher self-reported adherence
to TDF/FTC for PrEP over 48 weeks (‘adherent’ defined with
a composite endpoint of continued retention on PrEP and >
90% adherence to TDF/FTC at 48 weeks) compared to
MSM that have comprehensive SoC alone
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

42. CCTG 595 Focus Group 1
 Mixed Group of HIV+ and HIV- individuals
 About half of the participants knew of PrEP
 Liked the idea of medication reminders via text
 If to ask about unprotected sex, ask very directly
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

43. CCTG 595 Focus Group 2
 HIV- only
 Liked idea of medication reminders via text
 Specific Feedback on System:
» System needs to be varied; prefer no repeat messages
» Want daily messages for 48 weeks
» Want short messages, no names or med description.
» Want fun, witty, playful messages (e.g., snapple facts)
» Interested in selecting messages by domain related to interests;
not specifc messages (e.g., want to be surprised)
» Prefer not to have medication name or any mention of med or drug
» Provided good examples: “Pill O’Clock” “Med Thirty” “Y.O.L.O”
 Similar for other groups, SES?
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

44. Conclusions & Future Directions
iTAB :
1.Higher ARV adherence in HIV+/BD+ as compared to
observational study
2.Significantly better dose timing  improves therapeutic
coverage iin HIV+/BD+
3.Different stems/reminders may be needed by group (Meth
using)
4.Interventions for PrEP may need to be highly different from
those for HIV
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

45. Future Directions
1. Continue enrollment of iTAB-M (Refer Patients: 619-543-
5000)
2. Refine and implement system for CCTG 595
3. Evaluate iTAB over longer periods of time
4. Begin development of app for targeted group via SBIR
collaboration
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

46. Acknowledgments
 Participants  Fellows
 Funding Support » Pariya Fazeli, Ph.D.
» California HIV/AIDS Research Program ID- » Maria Marquine, Ph.D.
09-047, EI-11-SD-005  Staff
» NIDA R34 DA31058 » Jayraan Badiee
» NIMH/CSPAR P30 MH062512 » Candy Carson
 Co-investigators/Consultants » Eric Ellorin
» J. Hampton Atkinson, M.D. » Roberto Gallardo
» Colin Depp, Ph.D. » Ben Gouaux
» Igor Grant, M.D. » Jenn Marquie-Beck
» Richard Haubrich, M.D. » Amelia Poquette
» Scott Letendre, M.D. » Alexandra Rooney
» Sheldon Morris, M.D., M.P.H. » Crossby Vargas
» Tom Patterson, Ph.D. » Mel Willard
» Steven Safren, Ph.D.  Cal-IT2 Technical Experts
 Students » Kevin Patrick, M.D., M.S.
» Kaitlin Blackstone » Allison Flick
» Shereen Georges » Fred Raab
» Jessica Montoya » Mark Sullivan
» Carolina Posada
HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO

47. HIV NEUROBEHAVIORAL RESEARCH PROGRAM | UNIVERSITY OF CALIFORNIA, SAN DIEGO